Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Columbus, OH
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Fairfield, OH
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Fairfield, OH
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Charleston, SC
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Germantown, TN
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Nashville, TN
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Burlington, VT
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated:  10/9/2015
mi
from
Darlinghurst,
Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)
Status: Enrolling
Updated: 10/9/2015
mi
from
Darlinghurst,
Click here to add this to my saved trials
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated:  10/9/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated: 10/9/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated:  10/9/2015
Metropolitan Hospital
mi
from
New York, NY
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated: 10/9/2015
Metropolitan Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated:  10/9/2015
North General Hospital
mi
from
New York, NY
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated: 10/9/2015
North General Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated:  10/9/2015
Harlem Hospital
mi
from
New York, NY
Improving Heart Failure Care in Minority Communities
Improving Heart Failure Care in Minority Communities
Status: Enrolling
Updated: 10/9/2015
Harlem Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
Effect of Postoperative Hydrocortisone on Cardiovascular and Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated:  10/12/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Postop Steroids on Cardiovascular/Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
Effect of Postoperative Hydrocortisone on Cardiovascular and Respiratory Function in Neonates Undergoing Cardiopulmonary Bypass
Status: Enrolling
Updated: 10/12/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
A Multicenter, Phase II, Open Label Trial to Determine Optimal Imaging Parameters and Assess the Safety of LMI 1195 in Low Risk Patients and Heart Failure Patients With a History of Firing of an Implantable Cardioverter-Defibrillator
Status: Enrolling
Updated:  10/12/2015
Columbia University Medical College
mi
from
New York, NY
Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
A Multicenter, Phase II, Open Label Trial to Determine Optimal Imaging Parameters and Assess the Safety of LMI 1195 in Low Risk Patients and Heart Failure Patients With a History of Firing of an Implantable Cardioverter-Defibrillator
Status: Enrolling
Updated: 10/12/2015
Columbia University Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
A Comparison of Technegas® Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging in Subjects Being Evaluated for Pulmonary Embolism
Status: Enrolling
Updated:  10/13/2015
Barnes Jewish Hospital - Washington University
mi
from
St. Louis, MO
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
A Comparison of Technegas® Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging in Subjects Being Evaluated for Pulmonary Embolism
Status: Enrolling
Updated: 10/13/2015
Barnes Jewish Hospital - Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
A Comparison of Technegas® Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging in Subjects Being Evaluated for Pulmonary Embolism
Status: Enrolling
Updated:  10/13/2015
Columbia University Medical Center
mi
from
New York, NY
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
A Comparison of Technegas® Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging in Subjects Being Evaluated for Pulmonary Embolism
Status: Enrolling
Updated: 10/13/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated:  10/13/2015
University of Colorado School of Medicine/University of Colorado Hospital
mi
from
Aurora, CO
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated: 10/13/2015
University of Colorado School of Medicine/University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated:  10/13/2015
Massachusetts General Hospital
mi
from
Boston, MA
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated: 10/13/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated:  10/13/2015
The Mayo Clinic
mi
from
Rochester, MN
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated: 10/13/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated:  10/13/2015
North Estonia Medical Center
mi
from
Tallinn,
Local Assessment of Ventilatory Management During General Anesthesia for Surgery
Local Assessment of Ventilatory Management During General Anesthesia for Surgery - a Prospective Observational Multi-center Cohort Study
Status: Enrolling
Updated: 10/13/2015
North Estonia Medical Center
mi
from
Tallinn,
Click here to add this to my saved trials
Fluid Status of Outpatients With Dyspnea
Fluid Status of Outpatients With Dyspnea
Status: Enrolling
Updated:  10/13/2015
Vanderbilt University
mi
from
Nashville, TN
Fluid Status of Outpatients With Dyspnea
Fluid Status of Outpatients With Dyspnea
Status: Enrolling
Updated: 10/13/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Fluid Status of Outpatients With Dyspnea
Fluid Status of Outpatients With Dyspnea
Status: Enrolling
Updated:  10/13/2015
Wayne State University Hospital
mi
from
Detroit, MI
Fluid Status of Outpatients With Dyspnea
Fluid Status of Outpatients With Dyspnea
Status: Enrolling
Updated: 10/13/2015
Wayne State University Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated:  10/13/2015
Mass General Hospital
mi
from
Boston, MA
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Mass General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated:  10/13/2015
Henry Ford Hospital
mi
from
Detroit, MI
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated:  10/13/2015
Ohio State University
mi
from
Columbus, OH
Precision of IMED-4 Lung Fluid Measurements
Precision of IMED-4 Lung Fluid Measurements
Status: Enrolling
Updated: 10/13/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
MBCCOP - University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
University of Rochester Cancer Center CCOP Research Base
mi
from
Rochester, NY
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
University of Rochester Cancer Center CCOP Research Base
mi
from
Rochester, NY
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
A Prospective Randomized Controlled Multicenter Study of the Effect of Dalteparin on Quality of Life in Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
Use of Zenapax (Daclizumab) for the Prevention of Primary Acute Cardiac Rejection in Children and Adolescents. Ind Number: 10100
Status: Enrolling
Updated:  10/14/2015
Baylor College of Medicine
mi
from
Houston, TX
Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients
Use of Zenapax (Daclizumab) for the Prevention of Primary Acute Cardiac Rejection in Children and Adolescents. Ind Number: 10100
Status: Enrolling
Updated: 10/14/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Cardiology PC
mi
from
Birmingham, AL
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Vascular and Interventional Specialist of Orange County
mi
from
Orange, CA
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Vascular and Interventional Specialist of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
St. Vincent Medical Group
mi
from
Indianapolis, IN
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
St. Vincent Medical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Boston University School of Medicine
mi
from
Boston, MA
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
UNC School of Medicine
mi
from
Chapel Hill, NC
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
UNC School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Jobst Vascular
mi
from
Toledo, OH
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Jobst Vascular
mi
from
Toledo, OH
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
University of Oklahoma HSC
mi
from
Oklahoma City, OK
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
University of Oklahoma HSC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated:  10/14/2015
Texas Heart Institute
mi
from
Houston, TX
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
Status: Enrolling
Updated: 10/14/2015
Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials